Well, thank you tw0122. All I did was go online and read that the Clevland Clinic cured patients with Stem Cells. The problem for many is the expense hence not being able to do it. I agree with you and also think about the COVID-19 vaccine. It's not a vaccine at all it's a shot where you need boosters every 6 months. A real vaccine you get once in a lifetime example is polio and SmallPox. and how many generations ago? So they did that like 130 years ago but they can't cure other killer diseases in the 21st century! BS!
Recent IMUX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 11:01:07 AM
- Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis • PR Newswire (US) • 05/28/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 11:00:48 AM
- Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer • PR Newswire (US) • 05/27/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 11:00:48 AM
- Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors • PR Newswire (US) • 05/19/2026 10:30:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:34:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:01:04 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 10:36:56 AM
- Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/13/2026 10:30:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/06/2026 10:01:51 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 04/30/2026 09:15:46 PM
- Immunic to Participate in Investor and Medical Conferences in May • PR Newswire (US) • 04/30/2026 10:30:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 11:12:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:00:28 AM
- Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer • PR Newswire (US) • 04/28/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 12:30:43 PM
- Immunic, Inc. Announces 1-for-10 Reverse Stock Split • PR Newswire (US) • 04/23/2026 12:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/22/2026 08:56:18 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/17/2026 02:13:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:05:25 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/09/2026 08:30:55 PM
